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ABSTRACT Pairing high-throughput sequencing technologies with high-throughput mutagenesis enables genome-wide investiga-
tions of pathogenic organisms. Knowledge of the specific functions of protein domains encoded by the genome of the hepatitis C
virus (HCV), a major human pathogen that contributes to liver disease worldwide, remains limited to insight from small-scale
studies. To enhance the capabilities of HCV researchers, we have obtained a high-resolution functional map of the entire viral
genome by combining transposon-based insertional mutagenesis with next-generation sequencing. We generated a library of
8,398 mutagenized HCV clones, each containing one 15-nucleotide sequence inserted at a unique genomic position. We passaged
this library in hepatic cells, recovered virus pools, and simultaneously assayed the abundance of mutant viruses in each pool by
next-generation sequencing. To illustrate the validity of the functional profile, we compared the genetic footprints of viral pro-
teins with previously solved protein structures. Moreover, we show the utility of these genetic footprints in the identification of
candidate regions for epitope tag insertion. In a second application, we screened the genetic footprints for phenotypes that re-
flected defects in later steps of the viral life cycle. We confirmed that viruses with insertions in a region of the nonstructural pro-
tein NS4B had a defect in infectivity while maintaining genome replication. Overall, our genome-wide HCVmutant library and
the genetic footprints obtained by high-resolution profiling represent valuable new resources for the research community that
can direct the attention of investigators toward unidentified roles of individual protein domains.
IMPORTANCE Our insertional mutagenesis library provides a resource that illustrates the effects of relatively small insertions on
local protein structure and HCV viability. We have also generated complementary resources, including a website (http://hangfei-
.bol.ucla.edu) and a panel of epitope-taggedmutant viruses that should enhance the research capabilities of investigators study-
ing HCV. Researchers can now detect epitope-tagged viral proteins by established antibodies, which will allow biochemical stud-
ies of HCV proteins for which antibodies are not readily available. Furthermore, researchers can now quickly look up genotype-
phenotype relationships and base further mechanistic studies on the residue-by-residue information from the functional profile.
More broadly, this approach offers a general strategy for the systematic functional characterization of viruses on the genome
scale.
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In this work, we combined transposon insertion mutagenesiswith next-generation sequencing (NGS) to functionally charac-
terize a viral genome in a systematic manner. NGS techniques
have boosted deposition of new sequences in public databases. In
contrast, increases in our knowledge of viral gene function lag
behind and rely on testing individualmutant viruses. For genome-
scale studies, this approach would consume extensive time and
labor. Thus, virologists could benefit from rapid and high-
throughput methods that uncover relationships between se-
quenced genes and encoded functions. Themicrobiology field has
already integrated NGS with traditional transposon mutagenesis
for a systems-level analysis of microorganisms (1). In brief, these
strategies recover representative transposon insertion libraries
grown under defined selection conditions; sequencing of inser-
tion site junctions then determines the relative frequencies of each
insertion mutant at various points during the selection. In this
way, one experiment can report the contribution of thousands of
bacterial genome positions to the outcome of any selection. The
first additions of transposons to virologists’ tool kits demon-
strated the usefulness of insertionalmutagenesis for the functional
profiling of small viral genomes (2).We and others have increased
the profiling throughput by establishing a massively parallel pro-
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filing platform based on capillary electrophoresis; this resulted in
genome-wide functional profiles for hepatitis C virus (HCV),
Venezuelan equine encephalitis virus (VEEV), and norovirus (3–
5). In their studies of VEEV, Beitzel et al. improved the sensitivity
and precision of genetic footprinting through Roche 454 mas-
sively parallel sequencing (4). Recently, Heaton et al. took advan-
tage of the increased sequencing capacity of Illumina technology
in a genome-wide mutagenesis study of influenza virus (6), but
in-depth NGS-based analyses of mutagenized positive-stranded
RNA viruses such as HCV have been missing.
To increase the resolution of genetic footprinting, we profiled
HCV insertion mutant pools by Illumina sequencing. We chose
this virus because of HCV’s relevance to public health and the rich
body of existing literature, which includes experimentally deter-
mined protein structures. An estimated 130 to 170 million people
worldwide suffer from HCV infection (7). Over time, infection
can lead to chronic inflammation and liver cancer. HCV research
lacked infectious model systems to study the viral life cycle until
2005, when several groups reported successful propagation of
HCV in cell culture (8, 9). In host hepatocytes, translation of the
compact RNA genome (9.6 kb) produces ten viral proteins (10);
ascribing functions to these proteins remains an active area of
investigation. The core protein and envelope glycoproteins E1 and
E2 make up the structural components of the virus (11). Replica-
tion of the viral genome depends on the nonstructural proteins
NS3 to NS5B (12), as these proteins form the viral replication
complex. Virus particles do not appear to incorporate the p7 pro-
tein (13). In a replicon system, genome replication takes places
without p7 and NS2 (12, 14). However, more and more studies
have been implicating both p7 and NS2 in virion assembly (15).
Similarly, the nonstructural protein NS4B, which appears to play
many roles in genome replication (16), also appears to play a role
in postreplication steps (17–19).
In this study, we established a resource that illustrates the effect
of 5-amino-acid (aa) insertions on HCV viability. Insertions are
spread randomly across the entire HCV genome, with a single
insertion for every mutant, covering 99% of HCV codons. We
addressed whether the genetic footprints mirror the biological
functions and known structures of HCV proteins. We then used
the resource to guide us in the construction of infectious epitope-
tagged viruses, to screen the data set for insertions that affect later
steps of the virus life cycle, and to identify a critical region in
NS4B. This systems-level analysis of the HCV genome provides a
comprehensive resource that can benefit the entire research com-
munity by triggering mechanistic studies based on the profile’s
residue-by-residue information.
RESULTS
Combining random transposonmutagenesis with NGS yields a
comprehensive data set for profilingnearly every positionof the
HCV genome. How disruptions of local protein domains affect
HCV fitness remains an important question for virologists. More
broadly, how disruptions introduced by genomicmutations affect
protein function is of general interest to the biological commu-
nity. To create a comprehensive resource that addresses these
questions we combined transposon insertion sequencing with ge-
netic footprinting (see Fig. S1 in the supplementalmaterial). First,
we generated a library of HCV mutants harboring one 15-nt in-
sertion at one random location by Mu transposon insertion mu-
tagenesis and subsequent removal of the transposon fragment (see
Fig. S1A in the supplemental material). Following in vitro tran-
scription of theDNA library, we delivered the resultingHCVRNA
library into culturedHuh-7.5.1 cells for genetic selection.We then
recovered the total cell-associated RNA at 96 h posttransfection
(pool 1 [P1]) and after an additional passage of the conditioned
cell culturemedium (pool 2 [P2]). The originalmutagenizedRNA
library represented the unselected input pool (pool 0 [P0]).
To analyze the genetic footprints of the libraries from pools 0,
1, and 2, we enriched insertion sites and digitally counted each
insertion mutant site by NGS (see Fig. S1C and D in the supple-
mental material). Our experiment produced 6.4, 3.0, and 4.5 mil-
lion reads for pools 0, 1, and 2, respectively; the initial library from
pool 0 contained 7,978 unique insertion positions in genomic re-
gions coding for HCV proteins (see Dataset S1 in the supplemen-
tal material). Thus, our experiment covered 88% of the entire
9,102 nucleotides of protein-encoding space. The insertions
changed 99% of theHCV codons and 98% of encoded amino acid
positions. In conclusion, leveraging random transposon mu-
tagenesis and high-throughput insertion site sequencing yielded a
data set large enough to assay nearly every encoded amino acid
position.
Selection profiles of individual HCV genes vary according to
the functions of encoded proteins as structural or replication
complex proteins.To visualize the genetic footprints of this com-
prehensive insertion library, we generated a global insertion map
based on the sequencing data (Fig. 1A). The profile’s resolution
also allowed us to align these footprints with the domain organi-
zation of encoded proteins p7 and NS2 (Fig. 1B). We have up-
loaded higher-resolution maps of the remaining eight HCV pro-
teins to our HCV resource website (http://hangfei.bol.ucla.edu).
For each insertion position, we determined the number of se-
quencing reads in pools 0, 1, and 2. We also calculated the per-
centage of total insertion positions detected in the respective pro-
tein region in pools 1 and 2 relative to the number of insertion
positions detected in the input pool 0 (Table 1). In pools 1 and 2,
we detected 55% and 17%, respectively, of the original pool 0
insertionmutants (Table 1). This overall decrease in pools 1 and 2,
also seen in Fig. 1, suggested that passaging in cell culture indeed
exerted a selection pressure on mutant viruses. This selection
pressure was particularly strong for mutant viruses containing
insertions at positions located in the NS2 autoprotease domain,
NS3, NS4A, NS4B, and NS5B (Fig. 1 and Table 1). The trend
toward insertions in NS3-NS5B reflected the role of proteins
forming the replication complex, required early on in pool 1 to
initiate genome replication. In contrast, we detected 95 to 98% of
insertions in core, E1, E2, p7, and the NS2 transmembrane do-
main in pool 1 but only 15 to 45% in pool 2 (Table 1). The trend
toward insertions in core, E1, and E2 reflected the roles of struc-
tural proteins during the HCV life cycle: they are dispensable for
genome replication in pool 1 but essential for virus propagation in
pool 2. Note how insertions in NS2 and NS5A displayed a mixed
selection pattern; in pool 2 we detected only 5% of mutants in
certain regions of NS2 and NS5A (NS2 autoprotease domain and
NS5A RNA binding domain), whereas mutants in other regions
(NS2 transmembrane domain and rest of NS5A) persisted at 27%
and 76%, respectively (Table 1).
In summary, the functional map of the HCV genome revealed
very distinct patterns of selection. The separation of insertionmu-
tants based on shared selection patterns largely overlapped with
separation based on the genetically encoded function, namely, as
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structural components (core, E1, and E2) and replication-
complex components (NS3, NS4A, NS4B, and NS5B). This con-
gruence supported the validity of the functional profile.
Functional annotationof transmembraneprotein structures
supports the biological relevance of previously solved protein
structures.Todeterminewhetherwe couldmatch our screen data
with established functional HCV regions, we next focused our
analysis on protein domains with known nuclear magnetic reso-
nance (NMR) structures. Structures of entire membrane proteins
are difficult to obtain; thus, genetic footprints in membrane seg-
ments of the HCV genome can provide useful insight into
structure-function relationships. Note that the actual encoded
amino acid insertion represents one of three possible motifs de-
pending on an insertion’s locationwith respect to the overall HCV
reading frame. This results in 5-aa insertions each containing one
of the following sets of three constant amino acids: AAA, CGR,
and RPH/Q (note that the other two inserted amino acids depend
on the insertion location). First, we examined the C-terminal sig-
nal peptide region of the core protein. As a measure of fitness, we
calculated the ratio of normalized reads in pool 2 and reads in pool
1 (P2/P1). We then displayed the log of the P2/P1 ratios for the
AAA, CGR, and RPH/Q motifs as a heat map and color-coded a
previously solved structure (20) (Fig. 2A). P2/P1 ratios for inser-
tions in the membrane hydrophobic core, namely, the helix ex-
tending from aa 175 to 186, were highest for insertions encoding
alanine residues (Fig. 2A, cyan/blue colors for the AAA frame). In
contrast, insertions of proline or glycine were less tolerated.
Whereas alanine is known to have high helix-forming propensi-
FIG1 Functionalmap of the entireHCVgenome. (A)Digital counting of each insertionmutant in sequenced libraries. (Top) Bar graph of raw sequencing reads
from all 15-nt insertion mutants at each passage (input [P0], pool 1 [P1], and pool 2 [P2]). Each bar represents a unique mutant, and bar heights indicate
corresponding sequencing reads. (Bottom) Cartoon of HCV genome organization. (B) (Top) Closer look at the genetic footprint of insertion sites located in the
p7 and NS2 genes. (Bottom) Cartoon of p7 and NS2 protein domain organization. TM1 helix and TM2 helix, transmembrane helix 1 and 2; TMS1, TMS2, and
TMS3, transmembrane segments 1, 2, and 3.
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ties, the propensities of proline and glycine are poor (21). Thus,
the observed genetic footprints are consistent with incorporation
of alanine insertions into the local alpha-helical structure. On the
other hand, insertion of disruptive proline and glycine residues
would compromise helical structures, thereby impairing viral fit-
ness.
Second, wematched a publishedNMR structure of the p7 pro-
tein (22) to our genetic footprints (Fig. 2B). Tolerated insertion
mutants clustered within a region connecting the N-terminal he-
lix and first transmembrane helix (TM1). Moreover, amino acid
residues preceding transmembrane helix 2 (TM2) tolerated inser-
tion of theAAAmotif (Fig. 2B, stretch of four blue boxes [LTGL]).
Areas of insertion toleration in the p7 protein localized mostly to
turns and loops. Although the p7 protein is rather small (63 aa),
six p7 monomers can self-assemble to form larger ion channel
complexes (22). Annotation of the entire viroporin structure al-
lowed us to visualize an area tolerating all three insertionmotifs in
themiddle part of the ion channel (see Fig. S2A in the supplemen-
tal material [side view, yellow dashed area]). Most of the tolerated
insertions localized in a region forming an unstructured loop be-
tween the N-terminal helix and TM1 (aa 15 to 18). Thus, the
functional information from the genetic footprints allowed us to
define the boundaries of an area of toleration for 5-aa insertions
within the structural landscape of the oligomerized p7 ion chan-
nel. Finally, we explored the footprint of an additionalHCV trans-
membrane protein, NS2. When we overlaid the previously solved
structure of NS2’s membrane-bound portion (23, 24) with our
functional profile, we located tolerated regions proximal to a short
helix in transmembrane segment 1 and in a short loop connecting
transmembrane segments 2 and 3 (see Fig. S2B in the supplemen-
tal material). To summarize, our genetic footprints were consis-
tent with solved structures of HCV transmembrane proteins and
allowed us to match tolerated insertion regions with the protein’s
structure. Note that our screen determined the phenotypes of in-
sertion mutants in an infectious cell culture system that recapitu-
lated the entire virus life cycle. Thus, our functional profile sup-
ported the biological relevance of previously solved structures,
which were based on fragments of the core and NS2 proteins.
Identification of nonessential regions aids in the design of
viable epitope-tagged viruses. Our functional annotation of ex-
isting protein structures had already suggested that the genetic
footprints may identify regions of insertion toleration. Thus, we
wanted to use our footprints to direct the systematic insertion of
short protein sequences into the HCV genome. Genetic insertion
of epitope tags allows researchers to purify tagged viral proteins
and associated complexes from infected cells using well-
characterized tag-specific antibodies. Moreover, these antibodies
can aid in visualizing the subcellular localization of tagged pro-
teins. To identify candidate regions for epitope-tag insertion and
produce a map of hot spots tolerating insertions, we filtered the
functional profile based on calculated ratios between normalized
reads of pools 2 and 0 (P2/P0), as well as pools 1 and 0 (P1/P0),
using the following criteria: hot spot regions had to tolerate 5-aa
insertions regardless of the insertion reading frame at a P2/P0
ratio cutoff of 0.01 (Fig. 3A). Moreover, to remove any inser-
tional mutant viruses with defects in genome replication, we dis-
regarded any mutant with P1/P0 ratios of 0.1. This screen re-
vealed hot spots in core, E2, p7, NS2, and NS5A (Fig. 3A). After
considering the structural organization of these proteins, we
picked specific locations for the insertion of epitope tags (Fig. 3B).
Because the lengths and amino acid sequences of inserted epitopes
differed from those of the screen’s 5-aa insertions, we inserted a
panel of tags with various sizes and sequences (see Table S1 in the
supplemental material). This variety increased the likelihood of
producing viable epitope-tagged mutants. After constructing the
individual epitope-tagged mutants, we measured their fitness in
infectivity assays. Most epitope-tagged mutants remained viable
(Fig. 3B). Viruses with a 100-fold reduction in infectivity still pro-
duced robust levels of 1,000 infectious particles perml.Moreover,
we confirmed that the tags remained functional: antibodies
against the respective tag immunostained transfected cells viewed
by fluorescence microscopy (see Fig. S3 in the supplemental ma-
terial). The subcellular localization of tagged proteins was consis-
tent with previous studies (13, 24, 25) and detected only in in-
fected cells (see Fig. S3 in the supplemental material).
Epitope-tagged proteins offer added flexibility for multicolor
fluorescence microscopy due to the wide availability of anti-tag
antibodies. Multilabel microscopy often relies on primary anti-
bodies raised in different species. Species-specific fluorochrome-
conjugated secondary antibodies then allow the detection of mul-
TABLE 1 Gene-by-gene summary of the high-resolution functional profilea
Gene region Size (nt)
No. (%b) of insertion positions detected in:
Protein functionPool 0 Pool 1 Pool 2
Core 574 497 472 (95) 144 (27) Virion capsid
E1 576 498 479 (96) 123 (33) Virion envelope
E2 1100 983 938 (95) 158 (15) Virion envelope
p7 191 176 172 (98) 81 (45) Viroporin, assembly
NS2 TM domain 302 273 261 (96) 105 (27) Scaffold, assembly
NS2 protease domain 348 309 128 (41) 18 (5) Autoprotease
NS3 1895 1657 512 (30) 79 (3) RC, protease, helicase
NS4A 161 142 48 (32) 11 (4) RC, NS3 cofactor
NS4B 784 695 241 (34) 42 (5) RC, membranous web
NS5A domain I 638 542 175 (31) 39 (5) Binding to RNA/membranes
NS5A rest 760 664 575 (87) 508 (76) Regulatory, assembly
NS5B 1,710 1,481 361 (22) 127 (5) RC complex, polymerase
NS5B C terminus 64 61 49 (80) 39 (64) Membrane tail
Total 9,102 7,978 4,411 (55) 1,474 (17)
a RC, replication complex; TM, transmembrane.
b Percentage of the total number of insertion positions detected in pool 0.
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tiple proteins in the same sample. Using the 7177-FLAG virus,
which generates FLAG-tagged NS5A protein, we visualized the
spatial distribution of three viral proteins simultaneously using
primary antibodies against FLAG, HCV core, and E2 combined
with species-specific anti-rabbit, anti-mouse, and anti-human an-
tibodies (see Fig. S4 in the supplemental material). In addition,
staining of infected cells with the lipophilic dye BODIPY 493/503
provided a cellularmarker that revealed the location of lipid drop-
lets (LDs). We observed small areas of overlapping signals be-
tween the three viral proteins in the vicinity of LDs. Thus, our
epitope-tagged virus facilitated a four-color microscopy ap-
proach, which can visualize putative viral assembly sites.
Taken together, this work confirmed that we could tap our
HCV genetic footprint resource to guide the successful placement
of epitope tags for the production of replication-competent re-
porter viruses, which have a wide range of applications, such as
fluorescence microscopy.
Analysis of mutant viruses’ genetic footprints uncovers new
functional regions encoded by the HCV genome. In the analyses
described above, the data set’s genetic footprints agreed with
known functions and protein structures of HCV proteins. Next,
we wanted to test whether this resource could produce biological
information beyond a viral protein’s known functions. Based on
our finding that the selection profiles varied according to protein
function, we predicted that the values of P1/P0 and P2/P0 could
indicate whether an insertion affected an early or late step of the
HCV life cycle. Because insertions in core, E1, and E2 had average
P1/P0 ratios of 1.2, we hypothesized that insertions with P1/P0
ratios within the broad range of 0.65 to 1.85 would be competent
for genome replication. In contrast, P2/P0 ratios of0.01 would
be consistent with a defect at a later step of the life cycle and an
inability to produce infectious viral particles.
To find new nonstructural-protein functions not related to
traditional roles in genome replication, we applied the aforemen-
tioned criteria (along with a minimum of 20 for input P0 reads)
and generated a candidate list of 13 mutants with insertions in
nonstructural proteins (Table 2). Because insertions in NS4B
dominated this list (8 out of 13 mutants), we focused our valida-
FIG 2 Functional annotation of protein structures of HCV transmembrane regions. (A) Heat map of P2/P1 values in the C-terminal region of HCV core
protein. Each box provides the phenotype ofmutants containing an insertion after the indicated amino acid. Gray shows a lack of the respective insertionmutant
in pool 0.Mutants are separated by their AAA, CGR andRPH/Q amino acidmotifs. The color bar corresponds to a range of P2/P1 values [log(P2/P1) 1 to4].
Dictionary of secondary structure of proteins (DSSP) provides an overview of helices (zigzag lines) and unstructured loops (straight lines). (Top) Alignment of
core amino acid sequences of HCV strains from this study (strain FNX24) and deposited structure (PDB code 2LIF). (Bottom) Ribbon diagrams of annotated
structure, alongwith a tentativemodel of the peptide’s orientationwithin the endoplasmic reticulum (ER). (B)Heatmap of P2/P1 values in the p7 protein. DSSP
secondary structure indicates a turn (arc) toward the C-terminal end of the protein. PDB code 2M6X.
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tion efforts on NS4B. Individually cloned NS4B mutants with in-
sertions at positions 5571, 5584, 5597, 5607, and 5615 showed a
defect in spreading in cell culture, as evidenced by immunofluo-
rescence studies examining the number of HCV-positive cells af-
ter transfection of viral genome RNA (Fig. 4A). Moreover, the
insertions reduced infectivity to 1 to 6% of the levels seen for cells
transfected with a wild-type genome at 3 days following transfec-
tion (Fig. 4B).We observed similar defects in infectious virus pro-
duction at 1 and 5 days (Fig. 4B). Both our immunofluorescence
(Fig. 4B) and Western blotting (data not shown) suggested that
the insertions in NS4B reduced NS5A protein levels only slightly,
which indicated that viral RNA genomes still replicated robustly.
Thus, we conclude that the decreases in infectious virus particle
productionmay be due to additional defects in steps after genome
replication, such as viral assembly or egress. In summary, we iden-
tified a new region in theNS4B protein thatmay to be essential for
steps following genome replication. Importantly, we showed that
our data set could serve as a resource to screen for insertion mu-
tants that reveal protein regions with previously unrecognized bi-
ological functions.
DISCUSSION
In this study, high-throughput sequencing of transposon inser-
tion sites in the complete genome of HCV provided us with a
resource that captured biological functions of HCV proteins,
aided in the design of reporter viruses, and led to the identification
of new functional regions involved in later steps of the viral life
cycle. Note that the current functional profile of the HCV genome
improved upon our previously published profile (3) in several
ways (see Text S1 in the supplemental material). We could clearly
distinguish selection patterns for insertions in genes encoding the
structural proteins from those in genes encoding replication com-
plex proteins. In addition, the genetic footprints also reflected
biological functions mediated by different domains of viral pro-
FIG 3 Screening data set for hot spots tolerating small insertions. (A) Insertionmutants’ P2/P1 ratios across the HCV genome. Only data points that fall within
a cluster of3 consecutive insertion mutants with nonzero P2/P1 ratios were plotted. We discarded all insertion mutants with P1/P0 values of0.1 and P2/P0
values of 0.1. At the top is a cartoon depicting HCV genome organization. (B) Engineering infectious epitope-tagged HCV. The graph shows the fitness of
cloned epitope-tagged viruses. Fitness is the ratio ofmutant virus infectivity to thewild-type infectivity, as determined by a limiting dilution assay of supernatants
taken from transfected Huh-7.5.1 cells. Numbers (349 to 7177) refer to the genome position after which the sequence encoding the respective epitope tag was
inserted. TC, tetracysteine.
TABLE 2 Screening of functional profile produces a candidate list of nonstructural proteins with roles in steps following genome replicationa
Genome
position
HCV
protein Amino acid sequence
Count for:
P1/P0 P2/P0P0 P1 P2
5594 NS4B QAQDIQLRPQQPAMQAS 20 24 0 1.2 0
5571 NS4B GLLQQASAAAASKQAQD 211 264 2 1.2 0.007
5574 NS4B LLQQASNAAASKQAQDI 24 26 0 1.1 0
5583 NS4B QASKQAHAAAAQDIQPA 73 87 0 1.2 0
5584 NS4B ASKQAQCGRTQDIQPAM 699 471 3 0.7 0.004
5596 NS4B AQDIQPCGRKPAMQASW 39 42 0.2 1.1 0.006
5597 NS4B AQDIQPVRPQPAMQASW 190 134 0 0.7 0
5607 NS4B IQPAMQAAAAQASWPKV 535 521 2 1.0 0.003
6847 NS5A LPCEPECGRTEPDADVL 174 122 0.9 0.7 0.005
7290 NS5A VAGCALPAAALPPPKKA 35 38 0 1.1 0
7671 NS5B TTVCCSIAAASMSYSWT 82 112 0 1.4 0
8979 NS5B ILMVQDTAAADTLDQNL 36 41 0.2 1.1 0.006
8991 NS5B QDTLDQNAAAQNLNFEM 31 31 0 1.0 0
a Filtering criteria: P0 20; 0.65 P1/P0 1.85; P2/P0 0.01; only HCV proteins NS3 to -5B; P0, P1, and P2 total reads normalized to 1,000,000.
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teins. For example, a closer look at the NS2 profile (Fig. 1B) and
NS5A profile (Fig. 1A) revealed different selection patterns for
functionally distinct protein domains (see Text S2 in the supple-
mental material). At the same time, when examining pool 1 and 2
counts of single insertion mutants, we cannot rule out the possi-
bility that the electroporation and sequencing library preparation
steps introduce a certain level of biological noise in pools 1 and 2.
We suggest that when insertion positions are being selected for
follow-up experiments, further statistical analyses and data trim-
ming should be used to filter out this noise. Nonetheless, valida-
tion of screening results with individual mutants showed consis-
tent phenotypes for select insertion mutants of p7, NS3, NS4B,
NS5A, and NS5B (data not shown). Overall, the agreement be-
tween this study’s genetic footprints and known biological func-
tions of HCV proteins support the validity of this resource.
To further validate this resource, we surveyed the profile from
a structural angle, focusing on NMR structures of individual
membrane segments of HCV proteins. Our genetic footprints
match the structures in several ways. When we annotated protein
structures with the fitness values of insertional mutants, we ob-
served insertion toleration in external surface loops, unstructured
linker regions and a short turn separating two transmembrane
helices. These areas appear to accommodate additional amino
acid residues more readily, as seen in our previously published
functional profile of NS5B (3). Moreover, toleration in unstruc-
tured loops seems to be a general theme for viral proteins, as
evidenced by insertional mutagenesis studies of poliovirus and
norovirus (5, 26, 27). Our functional annotation of transmem-
brane proteins p7 and NS2 also highlights this method’s promise
in complementing the structural biology of membrane proteins.
Difficulties in the crystallization of membrane proteins and chal-
lenges in NMR structure determinations of larger proteins (28)
often prevent the determination of high-resolution structures,
which is the first step in studying structure-function relationships.
Therefore, we predict that the resource described in this paper,
which examines the phenotypes of insertions in membrane pro-
teins within the context of their native biological environment,
can support the biological relevance of solved membrane protein
structures and advance our comprehension of structure-function
relationships.
After we examined the validity of the functional profile, we
wanted to show applications of this resource. First, we created
maps of nonessential areas of the HCV genome. These maps
guided the construction of epitope-tagged viruses. This informa-
tion can guide the exact placement of exogenous sequences to
produce viable tagged viruses. Previously, transposon-mediated
random insertion mutagenesis in the coding region of NS5A and
subsequent selection of viable HCV replicons led to the identifi-
cation of two sites near the NS5A C terminus tolerating insertion
of heterologous sequences (29). This approach led to the genera-
tion of replicons and, later, infectious viruses encoding green flu-
orescent protein (GFP); these reagents have become essential tools
to directly visualize functional HCV replication complexes in host
FIG 4 Validation of NS4B’s role in later steps of the viral life cycle. (A)
Huh-7.5.1 cells were transfected with individually cloned mutants containing
insertions identified in Table 2. Controls were FNX24 parental virus (wild-
type), an E1E2 deletion mutant (most of the E1 and E2 coding regions were
deleted, making this mutant replication competent but assembly deficient),
and a Pol mutant (the mutant’s polymerase motif contains a GDD-to-GNN
mutation, making the mutant genome replication defective). Three days after
transfection of mutant RNA genomes, cells were fixed and processed for an
(Continued)
Figure Legend Continued
immunofluorescence assay using an anti-NS5A antibody. The Hoechst dye
provides a nuclear counterstain. Scale bar: 20m. (B) Infectivity of cell culture
supernatants taken from cells transfected with NS4B insertion mutants. We
collected cell supernatants at multiple time points after transfection of RNA
genomes and determined supernatant infectivity by limiting dilution assay.
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cells (29–31). In a similar way, we wanted to take advantage of our
genetic footprints in the entire HCV genome to identify hot spots
for insertion toleration. These insertion hot spots would then pro-
vide candidate regions for insertion of epitope tags. We identified
the N termini of E2, p7, and NS2 as prime candidates to insert
small peptides with limited fitness cost. Note that independent
studies have engineered individual epitope-tagged viruses at sim-
ilar locations (13, 24, 32–36). We expanded on these results by
revealing that these N termini tolerate various epitope tags, in
addition to the originally published tags. Our hot spot analysis for
the core and p7 proteins also yielded two unpublished internal
locations for the design of viable epitope-tagged viruses. We also
found that insertion into internal sites was more sensitive to the
size and amino acid identity of the actual inserted tag. An alterna-
tive approach (see Text S3 in the supplemental material), similar
to the one described by Moradpour et al., may be necessary to
develop epitope-tagged viruses for certain protein domains, i.e.,
E1, NS3, NS4A, NS4B, and NS5B, whose functions are easily dis-
rupted by insertions (29). Nevertheless, the genetic footprinting
approach outlined in this study can assist the rational design of
epitope-tagged viruses.
We also show the usefulness of an epitope-tagged reporter vi-
rus in multiplexed immunofluorescence assays, which revealed
areas of colocalization between the HCV structural proteins
core/E2 and the nonstructural protein NS5A. These areas were
close to LDs, which are cellular fat storage organelles that play
critical roles in the HCV assembly process (37, 38). In previous
confocal microscopy experiments, the structural proteins E2 and
core colocalized frequently adjacent to small lipid droplets (39).
Furthermore, core and NS5A signals overlap on LDs or on the
endoplasmic reticulum at various stages of virion assembly (37,
40). To our knowledge, our four-color microscopy images are the
first to confirm colocalization between these three viral proteins
(core, E2, and NS5A) around lipid droplets within the same cell.
Additional experiments that combine the use of epitope-tagged
viruses and high-resolution microscopy approaches will be
needed to further characterize these putative assembly sites. To-
ward this end, the recent application of three-color 3D superreso-
lution microscopy to the study of a FLAG-tagged E2 virus has
shown great promise in the analysis of assembly sites (41).
The second application of this resource took advantage of the
method’s semiquantitative measures of viral fitness. By limiting
our searches to particular P1/P0 and P2/P0 ratios, we generated a
candidate list of areas in nonstructural proteins potentially medi-
ating later steps of the viral life cycle. Insertions in a short stretch of
the NS4B gene dominated this list. This protein is a key player in
the formation of theHCV replication complex. In addition, NS4B
appears to play some role in postreplication of the HCV life cycle
(17–19, 42). Insertions from the candidate list fall between a pre-
dicted amphipathic alpha helix (43, 44) and a structurally resolved
alpha helix at the N terminus of the protein (44). Although a clear
role of this region in mediating later steps in the HCV life cycle,
such as particle assembly, has not yet been reported, a recent study
suggests that particular residues in the N terminus could play mi-
nor roles in HCV assembly (45). Additional studies will need to
investigate the exact mechanism of action underlying the role of
this NS4B region in later steps of the viral life cycle. In summary,
we envision our footprinting resource as an aid to preliminary
identification of new functional candidate regions, triggering de-
tailed individual studies that address possible mechanisms of ac-
tion.
In addition to the sequencing files, linked to the BioProject
entry PRJNA237836 at the NCBI BioProject database, we provide
this resource in a downloadable spreadsheet format (Dataset S1).
We have also designed a website to quickly screen for desired
phenotypes. In this way, the entire research community can re-
trieve the sequenced phenotypes of insertional mutant viruses.
Anyone can then reconstruct the corresponding insertionmutant
or introduce variations of mutations at the profiled amino acid
location for follow-up studies. These types of studies will be crit-
ical for examining how themutation of a select amino acid residue
affects HCV protein function. Although this study used genome-
wide transposon insertion sequencing to assess the basic require-
ments forHCV viability in cell culture, the approach lends itself to
analysis of requirements for growth or survival under any selective
condition. For example, studies comparing genetic footprints in
the presence and absence of an antiviral agent such as interferon
are ongoing in our laboratory. Moreover, analogous experiments
could examine the effect of knocking down or overexpressing cel-
lular host factors. Fitness analyses of HCV mutants in these cell
lines could shed light on detailed interactions of HCV with the
overexpressed/knocked-down factors. Finally, transposon inser-
tion sequencing experiments should strive to select mutagenized
libraries in additional model systems. Examples of these systems
would include primary hepatocytes as well as stem cell-derived
hepatocyte-like cells (46). Ultimately, applying the transposon in-
sertion sequencing approach to animal models of HCV infection
would be truly exciting. The emergence of new small animalmod-
els and improvement of existing models (47) make high-
throughput functional studies of viruses using in vivo models a
realistic goal in the near future.
MATERIALS AND METHODS
Cells. The Huh-7.5.1 cell line was kindly provided by Francis Chisari
(Scripps Research Institute, La Jolla, CA). The cells were cultured in sup-
plemented medium as described previously (3).
Plasmids and antibodies. We synthesized pFNX-HCV based on the
chimeric sequence of the genotype 2a J6/JFH1 virus. Construction of this
clone, which also included a mutation in the endogenous NotI site, and
the generation of envelope deletion and polymerasemutant controls were
described previously (48).We constructed individualmutant viruses with
15-nt insertions or epitope tags by site-directed PCR mutagenesis using
the primers listed inTable S1 in the supplementalmaterial, which also lists
antibodies and epitope tag sequences used.
Transposonmutagenesis.Theplasmid carrying FNX-HCVwasmod-
ified by in vitro bacteriophage Mu transposon mutagenesis (Thermo Sci-
entific, Waltham, MA), followed by incubation on plates containing
kanamycin and ampicillin to select for bacteria transformed with trans-
poson insertion-containing plasmids. We isolated mutant plasmids from
a total of one million individual bacterial colonies (100-fold the number
of possible insertions in the HCV genome) and pooled and digested plas-
mids with NotI enzyme (New England Biosciences, Ipswich, MA) to re-
move the transposon fragment, followed by a self-ligation step, which left
15 nucleotides (nt) (5=-N1N2N3N4N5TGCGGCCGCA-3=, whereN1 toN5
are 5 duplicated nucleotides from target DNA) randomly inserted across
the virus genome.
In vitro transcription, transfection, and insertion library passage.A
total of 16 g of the pFNX library DNA served as the template for in
vitro transcription using the T7 Ribomax Express kit (Promega,Madison,
WI). We transfected 120 g of DNase-treated RNA into 4.8 107 Huh-
7.5.1 cells by electroporation as described before (3). Cells were resus-
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pended in 40 ml of complete Dulbecco’s modified Eagle medium
(DMEM) and plated in T-75 culture flasks. Medium was replaced at 8 h
posttransfection, removed after an incubation period of 96 h, and tested
for infectivity. The resulting titer of this reconstituted mutant library was
8.4  104 focus-forming units (FFU) per ml. We passaged the library in
Huh-7.5.1 cells for another round at a lowmultiplicity of infection (MOI)
(0.2). Total RNAwas isolated from the cells using Tri-reagent (Molecular
Research Center Inc., Cincinnati, OH). TheDNase-treated, purified RNA
was used for functional profiling analysis.
Library preparation, Illumina sequencing, and analysis. Total ex-
tracted RNA from P0, P1, and P2 was reverse transcribed into cDNAwith
Superscript III (Life Technologies, Carlsbad, CA). The cDNA then served
as the template for PCR to amplify thirteen overlapping fragments cover-
ing the entire virus genome. We then enriched for insertion sites and
loaded the final products directly into the flow cell for sequencing. Text S4
in the supplemental material provides additional details on the enrich-
ment method. Sequencing of multiplexed insertion mutant libraries was
carried out using the Illumina IIx genome analyzer (Illumina, San Diego,
CA). Additional details on the sequencing data analysis are provided in
Text S4.
Mapping functional data to protein structures, cloning of individ-
ual insertionmutants, viral titration, and immunofluorescence.Text S4
in the supplemental material further describes how heat maps showing
P2/P1 ratios for the three insertion frames were obtained at each amino
acid position in defined stretches of core, p7, andNS2 proteins.Moreover,
experimental details on the cloning of individual epitope-tagged viruses
and NS4B insertion mutant viruses, as well as the functional assays, in-
cluding virus titration and immunofluorescence, are provided as well.
Accession numbers. Project metadata can be found under the acces-
sion number PRJNA237836 at the NCBI BioProject resource (http://
www.ncbi.nlm.nih.gov/bioproject). We have linked this experiment’s se-
quencing reads to this BioProject through the NCBI Sequence Read
Archive.
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